November 3, 2025

New Study to Assess Complement Inhibitor Iptacopan in Generalized Myasthenia Gravis – NeurologyLive

November 3, 2025

Exploring Long-Term Efficacy of Inebilizumab in Phase 3 Myasthenia Gravis Trial: Richard Nowak, MD, MS – NeurologyLive

November 3, 2025

Evolving Landscape of Myasthenia Gravis Treatment and Unmet Needs: Leila Darki, MD – NeurologyLive

November 2, 2025

Showcasing Sustained Benefits in Myasthenia Gravis Research at AANEM 2025: Kimberly Moran, PhD, MBA – NeurologyLive

October 30, 2025

Emerging Therapies in Myasthenia Gravis – NeurologyLive